1. Home
  2. RAYA vs VBIO Comparison

RAYA vs VBIO Comparison

Compare RAYA & VBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Erayak Power Solution Group Inc.

RAYA

Erayak Power Solution Group Inc.

N/A

Current Price

$0.86

Market Cap

1.3M

ML Signal

N/A

Logo Valion Bio Inc. Common Stock

VBIO

Valion Bio Inc. Common Stock

N/A

Current Price

$0.48

Market Cap

1.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RAYA
VBIO
Founded
2019
2016
Country
China
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3M
1.3M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
RAYA
VBIO
Price
$0.86
$0.48
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.0K
★ 312.7K
Earning Date
04-28-2027
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $780,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.31
$0.12
52 Week High
$5.62
$812.50

Technical Indicators

Market Signals
Indicator
RAYA
VBIO
Relative Strength Index (RSI) 18.39 21.34
Support Level $0.75 $0.12
Resistance Level $1.02 $4.39
Average True Range (ATR) 0.22 0.09
MACD -0.02 1.00
Stochastic Oscillator 12.35 3.62

Price Performance

Historical Comparison
RAYA
VBIO

About RAYA Erayak Power Solution Group Inc.

Erayak Power Solution Group Inc is engaged in the manufacturing, research and development (R&D), and wholesale and retail of power solution products. The group focuses on manufacturing new energy storage and inverter devices. Its product portfolio includes sine wave and off-grid inverters, inverters and gasoline generators, battery and smart chargers, and custom-designed products. The products are used principally in agricultural and industrial vehicles, recreational vehicles (RVs), electrical appliances, and outdoor living products. The company generates the majority of its revenue from Inverters. The company generates revenue from five main markets, which are China, Poland, Mexico, the U.K., and Portugal. It derives maximum revenue from China.

About VBIO Valion Bio Inc. Common Stock

Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.

Share on Social Networks: